COVID-19 is an emerging, rapidly evolving situation Show message Get the latest public health information from CDC Get the latest research information from NIH Get the latest information and resources from NHLBI NIH staff guidance on coronavirus (NIH Only)
Policies, Procedures, and Guidelines COVID-19: Information for NIH Applicants and Recipients of NIH Funding Get Email Alerts Receive automatic alerts about NHLBI Funding Awards and Policies Updates. Email (required) Guidelines General Funding Guidelines and Policies Interested in how the funding process works? ALERT – NEW RPPR SUBMISSION PROCEDURES FOR INCLUSION ENROLLMENT DATA IND/IDE authorization timing requirement for PAR-18-406 and PAR-18-407 Administrative Supplement Requests Applications with Direct Costs of $500,000 or More in Any One Year Appeals Policy and Procedures for Applicants Funding and Operating Guidelines Model Organisms Sharing Policy Security Policies, Forms and Procedures Guidelines for Research Funding Mechanisms P01 - Program Project Grants R13 - Conference Grants R18 - Research Dissemination and Implementation Grants R35 - Outstanding Investigator Award (OIA) and Emerging Investigator Award (EIA… T15 - Continuing Education Training Grants T32 - Ruth L. Kirschstein Institutional National Research Service Award X01 - NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders Guidelines for Human Subjects and Clinical Research Multicenter Clinical Studies Consent Form Guidelines Skills Development Core Proposals Recruitment ALERT – NEW RPPR SUBMISSION PROCEDURES FOR INCLUSION ENROLLMENT DATA Accrual of Human Subjects Certificates of Confidentiality Inclusion of Minorities and Women Human Stem Cell and Tissue Research Human Embryonic Stem Cell Research Human Tissue Repository Tissue Sharing in Informed Consent Data Management Data and Safety Monitoring Data Set Preparation Data Sharing General Guidance Reporting Adverse Events and Unanticipated Problems Third Party Involvement